Search
Close this search box.

Industry Thought Leaders

Our ever expanding library of blog articles, news and events have been categorized so you can find the information you need!

Summary of Isolation and Characterization of Impurities in Commercially Marketed Δ8-THC Products

The U.S. cannabis and hemp industry currently lacks comprehensive product characterization, primarily due to limited state testing regulations in this area and a lack of widespread implementation of current Good Manufacturing Practices (cGMP). While most states focus on testing a few active molecules, namely Δ9-THC, Δ9-THCA, CBD, and CBD-A, full identification of product components is generally not required.

Click here to read the full post

GMP Collective is a proud sponsor of the 2022 State of the States Report

The GMP Collective is a proud sponsor of the 2022 State of the States Report
published by the Americans for Safe Access (ASA). With over 150,000 active
supporters, ASA is the country’s largest member-based medical cannabis advocacy
group. Since 2014, the organization has published this comprehensive report that
grades the laws and regulations of U.S. states, D.C. and the four U.S. territories. If you
look at the reports over the years, it provides a snapshot of medical cannabis access
and regulatory progress. As time passes, ASA adapts the report with the times, adding
valuable sections, such as how states handled the COVID-19 response and starting to
give penalties for rules that limit patient access (Kentucky, New Mexico, and North
Carolina having the most penalties in this most recent report). ASA also updated the
rubric to prioritize the needs of patients today.

Click here to read the full post